Literature DB >> 11115397

Identification of a novel isoform of the cyclic-nucleotide phosphodiesterase PDE3A expressed in vascular smooth-muscle myocytes.

Y H Choi1, D Ekholm, J Krall, F Ahmad, E Degerman, V C Manganiello, M A Movsesian.   

Abstract

We have identified a new cyclic-nucleotide phosphodiesterase isoform, PDE3A, and cloned its cDNA from cultured aortic myocytes. The nucleotide sequence of its coding region is similar to that of the previously cloned myocardial isoform except for the absence of the initial 300-400 nt that are present in the latter, as confirmed by reverse-transcriptase-mediated PCR, 5' rapid amplification of cDNA ends and a ribonuclease protection assay. Expression in Spodoptera frugiperda (Sf9) cells yields a protein with catalytic activity and inhibitor sensitivity typical of the PDE3 family. The recombinant protein's molecular mass of approx. 131 kDa is compatible with translation from an ATG sequence corresponding to nt 436-438 of the myocardial PDE3A coding region. Antibodies against residues 424-460 (nt 1270-1380) and 1125-1141 (nt 3373-3423) of the myocardial isoform react with an approx. 118 kDa band in Western blots of homogenates of human aortic myocytes, whereas antibodies against residues 29-42 (nt 85-126) do not react with any bands in these homogenates. Our results suggest that a vascular smooth-muscle isoform ('PDE3A2') is a product of the same gene as the longer myocardial ('PDE3A1') and the shorter placental ('PDE3A3') isoforms and is generated pre-translationally in a manner that results in the absence of the 145 N-terminal amino acids of PDE3A1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11115397      PMCID: PMC1221541     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  Transcription by RNA polymerase II: initiator-directed formation of transcription-competent complexes.

Authors:  L Weis; D Reinberg
Journal:  FASEB J       Date:  1992-11       Impact factor: 5.191

Review 2.  Autoregulation and multifunctionality among trans-acting factors that regulate alternative pre-mRNA processing.

Authors:  W Mattox; L Ryner; B S Baker
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Physical mapping and promoter structure of the murine cAMP-specific phosphodiesterase pde4a gene.

Authors:  A E Olsen; G B Bolger
Journal:  Mamm Genome       Date:  2000-01       Impact factor: 2.957

5.  Identification of an alternate promoter in the rat androgen-binding protein/sex hormone-binding globulin gene that regulates synthesis of a messenger RNA encoding a protein with altered function.

Authors:  P M Sullivan; Y M Wang; D R Joseph
Journal:  Mol Endocrinol       Date:  1993-05

6.  Characterization of membrane-bound cyclic nucleotide phosphodiesterases from bovine aortic smooth muscle.

Authors:  M D Ivorra; A Le Bec; C Lugnier
Journal:  J Cardiovasc Pharmacol       Date:  1992-04       Impact factor: 3.105

7.  Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase.

Authors:  M Taira; S C Hockman; J C Calvo; M Taira; P Belfrage; V C Manganiello
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

8.  Cytosolic and sarcoplasmic reticulum-associated low Km, cGMP-inhibited cAMP phosphodiesterase in mammalian myocardium.

Authors:  C J Smith; J Krall; V C Manganiello; M A Movsesian
Journal:  Biochem Biophys Res Commun       Date:  1993-01-29       Impact factor: 3.575

9.  Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle.

Authors:  A Rascón; S Lindgren; L Stavenow; P Belfrage; K E Andersson; V C Manganiello; E Degerman
Journal:  Biochim Biophys Acta       Date:  1992-03-16

10.  Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase.

Authors:  E Meacci; M Taira; M Moos; C J Smith; M A Movsesian; E Degerman; P Belfrage; V Manganiello
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

View more
  13 in total

1.  Phosphodiesterase 3A binds to 14-3-3 proteins in response to PMA-induced phosphorylation of Ser428.

Authors:  Mercedes Pozuelo Rubio; David G Campbell; Nicholas A Morrice; Carol Mackintosh
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

2.  Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells.

Authors:  C J Busch; A R Graveline; K Jiramongkolchai; H Liu; L S Sanchez; K D Bloch
Journal:  J Physiol Pharmacol       Date:  2010-12       Impact factor: 3.011

Review 3.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

Review 4.  Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart.

Authors:  Chen Yan; Clint L Miller; Jun-ichi Abe
Journal:  Circ Res       Date:  2007-03-02       Impact factor: 17.367

5.  Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility.

Authors:  Silvia Masciarelli; Kathleen Horner; Chengyu Liu; Sun Hee Park; Mary Hinckley; Steven Hockman; Taku Nedachi; Catherine Jin; Marco Conti; Vincent Manganiello
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 6.  Phosphodiesterase inhibition in heart failure.

Authors:  Matthew Movsesian; Josef Stehlik; Fabrice Vandeput; Michael R Bristow
Journal:  Heart Fail Rev       Date:  2008-12-19       Impact factor: 4.214

Review 7.  Targeting phosphodiesterases in anti-platelet therapy.

Authors:  Matthew T Rondina; Andrew S Weyrich
Journal:  Handb Exp Pharmacol       Date:  2012

8.  Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.

Authors:  Ermanno Puxeddu; Marina Uhart; Chun-Chun Li; Faiyaz Ahmad; Gustavo Pacheco-Rodriguez; Vincent C Manganiello; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

Review 9.  Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects.

Authors:  W E Knight; C Yan
Journal:  Horm Metab Res       Date:  2012-09-05       Impact factor: 2.936

10.  Selective regulation of cyclic nucleotide phosphodiesterase PDE3A isoforms.

Authors:  Fabrice Vandeput; Nicolas Szabo-Fresnais; Faiyaz Ahmad; Changwon Kho; Ahyoung Lee; Judith Krall; Allan Dunlop; Mark W Hazel; James A Wohlschlegel; Roger J Hajjar; Miles D Houslay; Vincent C Manganiello; Matthew A Movsesian
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.